Quarterly assessment on the feasibility of insurance drug reimbursement eyed
Published: 2002-07-24 06:57:00
Updated: 2002-07-24 06:57:00
The Health Insurance Review Agency (HIRA) plans to conduct its quarterly assessment on the feasibility of insurance drug reimbursement involved in frequently occurring diseases based on the recently finalized program from the Central Evaluation Committee for Diagnosis Screening.
Under the HIRA's...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
